Creative Details

Quality Score: 10/10

The advertisement promotes Boston Scientific's advancements in interventional oncology and embolization solutions, emphasizing their commitment to advancing science for life.

Creative Information

CID:63ede56d-8dd4-474e-bb9b-1b7233aa6e37
CRID:2_206_520883
Domain:bostonscientific.com
Seat:BSW
Size:300x250
Bid:$2.69
Timestamp:11/1/2025, 3:04:29 AM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/12/2025, 3:36:03 PM5.78s
    adomain_analysissuccess11/12/2025, 3:35:22 PM3.10s
    adomain_capturesuccess11/12/2025, 3:35:19 PM0.22s
    ad_rendersuccess11/12/2025, 3:35:57 PM16.46s
    brand_mappingsuccess11/12/2025, 3:00:17 PM0.07s

    Analysis Results

    Ad Format: banner

    Brands: Boston Scientific

    Size:300x250
    Data Transferred:641.65 KB
    Render Time:7.81 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Science (IAB15)
    Creative Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    Domain Inferred IAB Categories:
    • Education (IAB5)
    • Health & Fitness (IAB7)
    • Science (IAB15)
    Domain Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    Total Ad Size:660.78 KB
    Requests Made:
    URLSize (KB)
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js?cache=r20110914222.95
    https://s0.2mdn.net/simgad/423718189025651958132.99
    https://ad.doubleclick.net/ddm/adj/N1991638.2055741ADTHEORANT/B34140308.429341999;dc_ver=106.314;sz=300x250;u_sd=1;nel=1;kw=310c8341-b412-11f0-9390-12a96e0e0ce7;dc_adk=2027040027;ord=oi5nkr;click=https%3A%2F%2Frtb.adentifi.com%2FClicks%3FcrId%3D520883%3BsId%3D803620%3BlId%3D108454%3BcId%3D20985%3BadExchange%3DBidSwitch%3Baction%3Dclick%3BadId%3D310c8341-b412-11f0-9390-12a96e0e0ce7%3BadThdId%3D92ef47372b4eb5d6e8488882c7bf24b0%3BengineId%3Di-0ad9ef5d8a0a4186a%3BdIp%3DOTguMTY4LjE5OS41%3BdIpv6%3D%3BadThdIdCode%3DWEB_MD5_V4%3BdealId%3D0%3BgeoId%3D80697%3BinventoryId%3D288374%3BrtdmIndicator%3D1%3Btimestamp%3D1761665067%3Blat%3DNDEuMzM%3Blong%3DLTk2LjA0%3Bdma%3DNjUy%3BstateCode%3D%3Bzip%3DNjgxMjI%3Bbsc%3DAUDIT%3Bredir%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=m!WIp5!mc0;stc=1;chaa=1;sttr=55;prcl=s73.13
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://ep1.adtrafficquality.google/bg/OUxjjEUpQOfCIZJamLGU7CrMz4_tjliTV20t0BhvBgo.js52.28
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74
    https://choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=20985&c=adtheorent01cont520883&w=300&h=250&js=pmw0&plc=tr&uid=92ef47372b4eb5d6e8488882c7bf24b020.43
    https://choices.trustarc.com/get?name=pmw2.js19.05
    https://www.googletagservices.com/dcm/dcmads.js16.68
    https://pagead2.googlesyndication.com/pagead/js/r20251111/r20110914/elements/html/omrhp.js11.63

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Raw Ad Markup

    <ins class='dcmads' style='display:inline-block;width:300px;height:250px'    data-dcm-placement='N1991638.2055741ADTHEORANT/B34140308.429341999'    data-dcm-rendering-mode='script'    data-dcm-https-only    data-dcm-click-tracker='https%3A%2F%2Frtb.adentifi.com%2FClicks%3FcrId%3D520883%3BsId%3D803620%3BlId%3D108454%3BcId%3D20985%3BadExchange%3DBidSwitch%3Baction%3Dclick%3BadId%3D310c8341-b412-11f0-9390-12a96e0e0ce7%3BadThdId%3D92ef47372b4eb5d6e8488882c7bf24b0%3BengineId%3Di-0ad9ef5d8a0a4186a%3BdIp%3DOTguMTY4LjE5OS41%3BdIpv6%3D%3BadThdIdCode%3DWEB_MD5_V4%3BdealId%3D0%3BgeoId%3D80697%3BinventoryId%3D288374%3BrtdmIndicator%3D1%3Btimestamp%3D1761665067%3Blat%3DNDEuMzM%3Blong%3DLTk2LjA0%3Bdma%3DNjUy%3BstateCode%3D%3Bzip%3DNjgxMjI%3Bbsc%3D${CLICK_URL_ENC}%3Bredir%3D'    data-dcm-rdid=''    data-dcm-keywords='310c8341-b412-11f0-9390-12a96e0e0ce7'    data-dcm-api-frameworks='[APIFRAMEWORKS]'    data-dcm-omid-partner='[OMIDPARTNER]'    data-dcm-ltd='false'    data-dcm-resettable-device-id=''    data-dcm-app-id=''>  <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins><img src='https://ir.surveywall-api.survata.com/s?eid=015c45ed-4194-4aef-9b58-60a0ee285a8e&cid=520883,803620,thepioneerwoman.com' alt=' ' title=' ' style='height:1px;width:1px;border:0'/><img src='https://rtb.adentifi.com/Imps?impId=1;adId=310c8341-b412-11f0-9390-12a96e0e0ce7;lId=108454;sId=803620;cId=20985;crId=520883;adThdId=92ef47372b4eb5d6e8488882c7bf24b0;adExchange=BidSwitch;engineId=i-0ad9ef5d8a0a4186a;dealId=0;geoId=80697;inventoryId=288374;rtdmIndicator=1;timestamp=1761665067;property=thepioneerwoman.com;dIp=OTguMTY4LjE5OS41;dIpv6=;adThdIdCode=WEB_MD5_V4;thirdPartyIdType=1;npiKey=3354668700389411774;hhId=286781280;cuid=cuid_2a085357-7d02-11ef-90b3-12f7f0962d75' style='display:none; width:0px; height:0px;' /><script src="https://tags.bkrtx.com/js/bk-coretag.js"></script><script>bk_addPageCtx("id","cuid_2a085357-7d02-11ef-90b3-12f7f0962d75");bk_allow_multiple_calls = true;bk_use_multiple_iframes = true;bk_send_statid_payload = true;bk_use_image = true;bk_callback = true;bk_doJSTag(18840, 4);</script><img src='https://sb.scorecardresearch.com/p?c1=9&c2=16077523&c3=2&cs_xi=cuid_2a085357-7d02-11ef-90b3-12f7f0962d75&rn=310c8341-b412-11f0-9390-12a96e0e0ce7' height='0' width='0' /><span id="te-clearads-js-adtheorent01cont520883"><script type="text/javascript" src="//choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=20985&c=adtheorent01cont520883&w=300&h=250&js=pmw0&plc=tr&uid=92ef47372b4eb5d6e8488882c7bf24b0"></script></span><img src="https://us-east-sync.bidswitch.net/sync?ssp=kargo&amp;dsp_id=206&amp;imp=1" alt=" " style="display:none"/>

    Creatives

    Creative Screenshot 1